Tag Archives: SGMO

Wednesday’s Highlights at Noon: Rosetta Genomics Ltd (ROSG), Yingli (YGE), MannKind (MNKD), Microvision (MVIS), Sangamo Biosciences (SGMO)

So far Wednesday, September 5, NASDAQ is down -2.23% and the S&P is down -0.06%. Here are this morning’s most active stocks: Rosetta Genomics Ltd (NASDAQ:ROSG), Yingli (NYSE:YGE), MannKind (NASDAQ:MNKD), Microvision (NASDAQ:MVIS) and Sangamo Biosciences (NASDAQ:SGMO). Rosetta Genomics Ltd is

Wedbush Keeps a Hold Rating on Sangamo Biosciences (SGMO)

Wedbush analyst Liana Moussatos reiterated a Hold rating on Sangamo Biosciences (NASDAQ: SGMO) today and set a price target of $10. The company’s shares opened today at $14.80. According to TipRanks.com, Moussatos is a 3-star analyst with an average return

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sangamo Biosciences (NASDAQ: SGMO) and Neurocrine (NASDAQ: NBIX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sangamo Biosciences (NASDAQ:SGMO) and Neurocrine (NASDAQ:NBIX). Sangamo Biosciences (SGMO) In a report released today, Liana Moussatos from Wedbush reiterated a Hold rating on Sangamo Biosciences,

Sangamo Biosciences Receives a New Rating from Cowen & Co.

Sangamo Biosciences (NASDAQ: SGMO) received a Buy rating from Cowen & Co. analyst Ritu Baral today. The company’s shares opened today at $15.45. According to TipRanks.com, Baral is a top 100 analyst with an average return of 37.6% and a

Tuesday’s Midday Stock Update: Sears Holdings (SHLD), Amedica (AMDA), Antares Pharma (ATRS), Sangamo Biosciences (SGMO), Clean Diesel Technologies (CDTI)

So far Tuesday, March 27, NASDAQ is down -2.99% and the S&P is down -0.1%. Here are this morning’s most active stocks: Sears Holdings (NASDAQ:SHLD), Amedica (NASDAQ:AMDA), Antares Pharma (NASDAQ:ATRS), Sangamo Biosciences (NASDAQ:SGMO) and Clean Diesel Technologies (NASDAQ:CDTI). Sears Holdings

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sangamo Biosciences (NASDAQ: SGMO) and VBI Vaccines (NASDAQ: VBIV)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sangamo Biosciences (NASDAQ: SGMO) and VBI Vaccines (NASDAQ: VBIV). Sangamo Biosciences (NASDAQ: SGMO) Wedbush analyst Liana Moussatos reiterated a Hold rating on Sangamo Biosciences (NASDAQ: